Incidence and significance of GATA3 positivity in gallbladder adenocarcinoma. Hum Pathol 2020 Dec;106:39-44
Date
09/30/2020Pubmed ID
32991930DOI
10.1016/j.humpath.2020.09.012Scopus ID
2-s2.0-85094556628 (requires institutional sign-in at Scopus site) 5 CitationsAbstract
GATA3 immunostaining is a sensitive marker for mammary and urothelial carcinomas. It is routinely used in surgical pathology during workup of carcinomas of unknown origin. To the best of our knowledge, this is the first focused study of GATA3 expression in gallbladder adenocarcinomas. In this study, we evaluated GATA3 expression in 38 gallbladder adenocarcinomas. Eight of 38 (21%) gallbladder adenocarcinomas were positive for GATA3. The expression of GATA3 tended to be moderate to strong when present. It was patchy (<50% positivity) in 4 cases, characterized by discrete clusters or groups of malignant cells with areas of intervening negative tumor cells, whereas it was diffuse (>50% positivity) in the other 4 cases. GATA3 expression did not show any significant correlation with clinicopathologic features such as sex, histologic grade, perineural invasion, vascular invasion, pathologic stage, or distance metastasis. The results of our study show that a subset of gallbladder adenocarcinomas (21%) can be GATA3 positive. Awareness of this phenomenon is important while working up GATA3-positive carcinomas immunohistochemically.
Author List
Guo W, Lee W, Lu Y, Li X, Chandan VSAuthor
Whayoung Lee MD Assistant Professor in the Pathology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdenocarcinomaAdult
Aged
Aged, 80 and over
Biomarkers, Tumor
Female
GATA3 Transcription Factor
Gallbladder Neoplasms
Humans
Immunohistochemistry
Male
Middle Aged
Predictive Value of Tests
Prognosis
Retrospective Studies
